Funding for this research was provided by:
National Institutes of Health (R01 CA20441, P30 CA008748)
Received: 9 May 2018
Accepted: 7 August 2018
First Online: 28 August 2018
: All in vivo studies and procedures were performed in accordance with an approved protocol from the Institutional Animal Care and Use Committee at Memorial Sloan Kettering Cancer Center (MSK).
: Not applicable.
: Jose F. Ponte is an employee of ImmunoGen, Inc. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.